AOD9604
Research Compound · 1 vial x 10mg
$89
| Pack size | 1 vial x 10mg |
| Also known as | hGH fragment 176–191 (Tyr-modified) |
| Compound type | Synthetic 16-amino-acid peptide |
| Sequence | YLRIVQCRSVEGSCGF (disulfide Cys7–Cys14) |
| Molecular formula | C78H123N23O23S2 |
| Molecular weight | 1815.1 g/mol |
| CAS number | 221231-10-3 |
| Form | Lyophilized powder |
| Purity | 99% Pure |
| Storage | Store lyophilized powder at -20°C. Once reconstituted, refrigerate at 2-8°C and use within the timeframe indicated by your lab protocol. |
| Intended use | Laboratory research only |
This product is sold exclusively for laboratory research use by qualified professionals and institutions. It is not a drug, food, cosmetic, or dietary supplement, and is not approved for use in humans or animals. Handling must be performed only by trained personnel in a controlled research setting.
Research overview
AOD9604 is a 16-amino-acid fragment of the C-terminal region of human growth hormone (residues 176–191) with a tyrosine added at the N-terminus. It was developed to study growth hormone C-terminal fragment activity separately from IGF-1 signaling; its clinical development ended in 2007.
Research areas
- Adipocyte signaling models
- Growth hormone structure–function
- IGF-1-independent signaling
Sources
Handling and storage
Store lyophilized powder at -20°C. Once reconstituted, refrigerate at 2-8°C and use within the timeframe indicated by your lab protocol.